C.M. Bidwell & Associates’s Elevance Health ELV Stock Holding History

C.M. Bidwell & Associates’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-222	Closed	-$114K	–	527
2022 Q4	$114K	Hold	222	–	–	0.09%	206
2022 Q3	$101K	Hold	222	–	–	0.08%	215
2022 Q2	$107K	Buy	+222	New	+$110K	0.08%	207
2021 Q4	–	Sell	-3	Closed	-$1K	–	571
2021 Q3	$1K	Hold	3	–	–	﹤0.01%	536
2021 Q2	$1K	Buy	+3	New	+$1.15K	﹤0.01%	538
2019 Q3	–	Sell	-2,970	Closed	-$838K	–	443
2019 Q2	$838K	Sell	2,970 -70	-2%	-$19.1K	0.83%	24
2019 Q1	$872K	Sell	3,040 -175	-5%	-$50.6K	0.87%	20
2018 Q4	$844K	Buy	+3,215	New	+$884K	0.92%	17
2017 Q3	–	Sell	-1,070	Closed	-$201K	–	326
2017 Q2	$201K	Buy	1,070 +5	+0.5%	+$898	0.04%	149
2017 Q1	$176K	Hold	1,065	–	–	0.04%	168
2016 Q4	$153K	Buy	+1,065	New	+$143K	0.04%	180
2016 Q1	–	Sell	-34,910	Closed	-$4.87M	–	276
2015 Q4	$4.87M	Sell	34,910 -28,065	-45%	-$3.87M	1.16%	23
2015 Q3	$8.82M	Sell	62,975 -300	-0.5%	-$45.1K	2.17%	1
2015 Q2	$10.4M	Buy	63,275 +1,210	+2%	+$193K	2.32%	3
2015 Q1	$9.58M	Sell	62,065 -40	-0.1%	-$5.7K	2.12%	5
2014 Q4	$7.8M	Buy	+62,105	New	+$7.67M	1.78%	14

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

C.M. Bidwell & Associates's ELV Position: Q1 2023 in Review

C.M. Bidwell & Associates sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 222 shares — an estimated $114K sold.

C.M. Bidwell & Associates first reported a position in ELV in Q4 2014 and held it in 16 quarters. The position peaked at $10.4M in Q2 2015. 1,517 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

C.M. Bidwell & Associates reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
C.M. Bidwell & Associates sold 222 Elevance Health shares in Q1 2023, an estimated $114K.
C.M. Bidwell & Associates first reported a position in Elevance Health in Q4 2014 and held it in 16 quarters.
C.M. Bidwell & Associates's Elevance Health position peaked at $10.4M in Q2 2015.
1,517 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2023, filed 12 May 2023.